Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,506 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07070583Recruiting
Effect of Leg Artery Blockage Treatment on Blood Pressure
This study looks at how treating blocked arteries in the lower belly and groin area affects blood pressure. If you have a long blockage in your main artery or the arteries to your legs that causes pain or trouble walking, this trial may help understand if treatment improves your blood pressure.
ArnhemAges 18 years+ - NCT06932679Recruiting
How people with Parkinson’s cross obstacles
This study looks at how people with and without Parkinson’s disease see and step over obstacles while walking. It aims to understand differences in perception and movement to help improve safety and mobility for people with Parkinson’s.
HaifaAges 20–80 - NCT06944418Recruiting
Eosinophil function in eosinophilic lung disease
This study looks at how a type of white blood cell (eosinophil) works differently in people with eosinophilic lung diseases. It may help doctors understand these conditions better and find new treatments.
Beijing, Beijing MunicipalityAges 18–90 - NCT06964763Enrolling by invitation
Minimally invasive surgery for pilonidal sinus
This trial tests a mini-invasive surgery for pilonidal sinus that hasn't come back before. It may offer a less painful recovery and faster healing.
HelsinkiAges 18 years+ - NCT06979531RecruitingPhase 2
A study of IMVT-1402 for Sjogren's disease with moderate to severe symptoms
This trial tests an experimental drug, IMVT-1402, in adults with primary Sjogren's disease who have moderate to severe symptoms. The goal is to see if it can reduce disease activity safely.
Covina, CaliforniaAges 18–74 - NCT06924359Recruiting
Eye scans and blood tests for early Alzheimer's detection
This study uses special eye scans and blood tests to find early signs of Alzheimer's disease. It aims to detect the disease before memory loss becomes severe, so treatment can start sooner.
BeijingAges 50 years+ - NCT06871839Recruiting
A study of lencanumab for early Alzheimer's disease
This trial tests an investigational drug called lencanumab for people with early Alzheimer's disease. The goal is to see if it can help with memory and thinking by targeting brain changes caused by Alzheimer's.
BeijingAges 50–90 - NCT06794294RecruitingPhase 1/Phase 2
Stem cell therapy for chronic shoulder pain from partial rotator cuff tear
This trial tests whether a single injection of stem cells from donated umbilical cord tissue can help people with a partial rotator cuff tear that hasn't healed with standard treatments like physical therapy or injections. If you have had shoulder pain for at least 3 months and a partial tear confirmed by MRI or ultrasound, you may be eligible.
Seoul, KoreaAges 19 years+ - NCT06755190Recruiting
AI help for eye disease decisions
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
Zhuhai, GuangdongAges Any age - NCT06777914Recruiting
Genes linked to rare liver disease and cancer risk
This study looks at whether certain family-related genes make people more likely to develop liver or bile duct cancers without a clear cause. If you had surgery or a transplant for one of these cancers and have had unexplained high liver enzymes or itching, this trial may help find genetic clues.
Bologna, BolognaAges 1 year+ - NCT06794359Enrolling by invitation
Comparing minimally invasive vs. traditional bypass for multi-vessel heart disease
This study compares two types of heart bypass surgery for people with blockages in multiple heart arteries: a newer, less invasive technique (minimally invasive CABG) versus the traditional open-chest approach. It aims to see which approach leads to better recovery and outcomes.
São Paulo, São PauloAges 18 years+ - NCT06796751Recruiting
Better DNA testing for unclear genetic results
This study uses a new, advanced DNA sequencing method (long-read sequencing) to try to clarify unclear or incomplete genetic test results. If you or a family member have had genetic testing that left unanswered questions, this trial may help find more definite answers.
Bologna, BolognaAges 4 weeks+ - NCT06677320Recruiting
What really matters in rotator cuff disease
This study looks at what it means for rotator cuff problems to be clinically important—how they affect your daily life and what counts as meaningful improvement. It helps doctors better understand your symptoms and recovery.
KırklareliAges 18 years+ - NCT06559878Enrolling by invitation
Liver Mitochondria Study in Fatty Liver Disease
This study looks at how the liver's mitochondria (the energy powerhouses of cells) work in people with fatty liver disease. Participants will have an MRI scan and receive a small amount of fat solution through an IV to see how the liver processes fat.
Helsinki, UusimaaAges 18–75 - NCT06506513Recruiting
Can exercise help fatty liver disease?
This study tests whether a program of physical activity can reduce fat in the muscles and liver of people with MASLD, a type of fatty liver disease linked to metabolism. It looks at how exercise might help improve liver health.
BrusselsAges 18–70 - NCT06555367Recruiting
Scleral lenses for eye surface diseases
This trial tests whether special contact lenses called scleral lenses can help people with certain eye problems, such as an irregularly shaped cornea after surgery or injury. The lenses may improve vision and comfort for those with these conditions.
Hangzhou, ZhejiangAges 18 years+ - NCT06549231RecruitingPhase 3
Rituximab and mycophenolate for scleroderma lung disease
This trial tests whether combining two drugs, rituximab and mycophenolate mofetil, is safe and works better than standard care for lung scarring caused by scleroderma. It may be an option if your lung disease is severe or getting worse.
ToursAges 18–100 - NCT06591000Recruiting
Comparing two types of tricuspid valve replacements
This trial compares two types of replacement valves for the tricuspid valve: a donated human valve (allograft) and a stented biological valve (made from animal tissue). The goal is to see which works better and lasts longer.
ChelyabinskAges 18–70 - NCT06322290Recruiting
Study of serious bacterial infections
This study is for people diagnosed with serious bacterial infections, specifically those caused by certain bacteria (pneumococcus, meningococcus, or haemophilus influenzae type b) that have spread throughout the body. The goal is to learn more about these infections and improve care.
AdriaAges 1 day–70 years - NCT06226844Recruiting
Can a vibration device help people with leg artery disease walk further?
This study tests a device called BeatMove to see if it can improve walking distance for people with blocked leg arteries that cause pain when walking. It may help if you have this condition and already take medicines for it.
NîmesAges 18 years+ - NCT06182748Recruiting
Physical activity and lung scarring
This study tests if a supervised exercise program, 3 times a week, helps people with lung scarring (fibrosing interstitial lung disease). It may improve your breathing and quality of life.
Bobigny, Seine Saint DenisAges 18 years+ - NCT06318949Recruiting
Albumin changes as early signs of chronic liver disease
This study is looking at whether changes in a protein called albumin can help find liver disease earlier. It is for people who have some liver scarring but no serious complications.
AngersAges 18 years+ - NCT06324838Recruiting
Surgery study for Crohn's disease in the ileocecal area
This trial compares two surgical techniques for removing the affected part of the intestine in people with Crohn's disease. It aims to see if removing more tissue around the blood vessels leads to better outcomes.
OdenseAges 18 years+ - NCT06075966Enrolling by invitation
A new surgery for lumbar disc disease without fusion
This trial tests a surgical technique that treats a damaged disc in your lower back without permanently fusing the bones together. It may be an option if you have had at least 3 months of other treatments like physical therapy or medication and they have not helped enough.
Jinan, ShandongAges 18–85
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,506 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.